Canopy Growth Corporation (TSX:WEED)
1.430
+0.070 (5.15%)
May 20, 2026, 4:00 PM EST
Canopy Growth Revenue
Canopy Growth had revenue of 74.54M CAD in the quarter ending December 31, 2025, a decrease of -0.29%. This brings the company's revenue in the last twelve months to 278.39M, up 0.59% year-over-year. In the fiscal year ending March 31, 2025, Canopy Growth had annual revenue of 269.00M, down -9.47%.
Revenue (ttm)
278.39M
Revenue Growth
+0.59%
P/S Ratio
1.86
Revenue / Employee
289.99K
Employees
960
Market Cap
517.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 269.00M | -28.15M | -9.47% |
| Mar 31, 2024 | 297.15M | -36.11M | -10.83% |
| Mar 31, 2023 | 333.25M | -142.45M | -29.94% |
| Mar 31, 2022 | 475.70M | -70.95M | -12.98% |
| Mar 31, 2021 | 546.65M | 147.88M | 37.08% |
| Mar 31, 2020 | 398.77M | 172.43M | 76.18% |
| Mar 31, 2019 | 226.34M | 148.39M | 190.37% |
| Mar 31, 2018 | 77.95M | 38.05M | 95.38% |
| Mar 31, 2017 | 39.90M | 27.20M | 214.16% |
| Mar 31, 2016 | 12.70M | 10.33M | 435.60% |
| Mar 31, 2015 | 2.37M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Verano Holdings | 1.14B |
| Cresco Labs | 895.33M |
| Knight Therapeutics | 510.45M |
| Aurora Cannabis | 373.12M |
| TerrAscend | 365.43M |
| DRI Healthcare Trust | 275.81M |
| Organigram Global | 274.19M |
| Cronos Group | 222.69M |
Canopy Growth News
- 4 days ago - Canopy Growth Provides Update on Financial Reporting and Announces Fourth Quarter and Fiscal Year 2026 Financial Results to be Presented on June 15, 2026 - Business Wire
- 5 days ago - Is Canopy Growth Stock Finally Setting Up for a Real Turnaround? - The Motley Fool
- 6 days ago - Canadian Marijuana Stocks Showing Strong Momentum in May - MarijuanaStocks
- 6 days ago - Canopy Growth Is One of the Market's Most Polarizing Stocks: 3 Scenarios for the Next 12 Months - The Motley Fool
- 13 days ago - Canopy Growth, Spectrum expand Minor Cannabinoid softgel lineup - TheFly
- 13 days ago - Canopy Growth and Spectrum Therapeutics Expand Medical Portfolio with New 30 and 90-Pack Softgels and Enhanced Dosing Options - Business Wire
- 20 days ago - 3 Canadian Marijuana Stocks That Could Benefit From U.S. Reform - MarijuanaStocks
- 23 days ago - Canopy Growth Stock Is Jumping. Is It Overdue for a Much Bigger Rally? - The Motley Fool